AI Image
FDA Announces Recall on Blood Pressure Medication-More Than 13,000 Bottles Affected Nationwide
AOL.com • • health
Key Points:
- Over 13,000 bottles of the blood pressure medication chlorthalidone have been recalled nationwide due to failed dissolution specifications, which may reduce the drug's effectiveness.
- The FDA classified the recall as Class II, indicating a low chance of serious health consequences but potential for temporary or reversible effects.
- The recalled product, manufactured by Inventia Healthcare Limited, includes 25 mg chlorthalidone tablets in 100-count bottles with batch code RISA24002 and expiration date 04/2027.
- Patients with affected bottles are advised to contact their healthcare provider before making any changes to their medication, as stopping treatment abruptly can be risky.
- This recall follows a similar one in June involving over 11,000 bottles of chlorthalidone from the same manufacturer with the same issue.
